MENU
PTNT
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Palatin Technologies (PTNT) Ownership - Who owns Palatin Technologies?
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.62M
P/E Ratio
N/A
Total Cash
422.44K
Projected Growth
N/A
Total Debt
262.22K
Revenue
N/A
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash/Share
0.45
Total Debt/Equity
N/A
Revenue/Share
0.84 USD as % of share price
Fundamentals
PTNT
Capitalization
9.62M
P/E Ratio
N/A
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash
422K
Total Cash/Share
0.45
Total Debt
262K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.84%
Revenue
N/A
ROE
N/A
Book Value
-6.39M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
286K
Current Ratio
0.32
Current Revenue Per Employee
11666.67
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
274M
Shares Outstanding - Current
930K
Total Liabilities
10.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-81.355
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PTNT showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information